Objectives: Therapeutic hypothermia is standard of care in management of moderate/severe hypoxic-ischemic encephalopathy. Persistent pulmonary hypertension of the newborn is associated with hypoxic-ischemic encephalopathy and is exacerbated by hypoxemia and hypercarbia. Gas exchange is assessed by arterial blood gas analysis (with/without correction for body temperature), pulse oximetry, and end-tidal Co 2 . Design: A retrospective chart review. Settings: Regional perinatal center in Western New York. Patients: Fifty-eight ventilated neonates with indwelling arterial catheter on therapeutic hypothermia. Intervention: None. Measurement and Main Results: We compared pulse oximetry, Pao 2 , end-tidal Co 2 , and Paco 2 during hypothermia and normothermia in neonates with hypoxic-ischemic encephalopathy using 1,240 arterial blood gases with simultaneously documented pulse oximetry. During hypothermia, pulse oximetry 92-98% was associated with significantly lower temperature-corrected Pao 2 (51 mmHg; interquartile range, 43-51) compared with normothermia (71 mmHg; interquartile range, 61-85). Throughout the range of pulse oximetry values, geometric mean Pao 2 was about 23% (95% CI, 19-27%) lower during hypothermia compared with normothermia. In contrast, end-tidal Co 2 accurately assessed temperature-corrected Paco 2 during normothermia and hypothermia. Conclusions: Hypothermia shifts oxygen-hemoglobin dissociation curve to the left resulting in lower Pao 2 for pulse oximetry. Monitoring oxygenation with arterial blood gas uncorrected for body temperature and pulse oximetry may underestimate hypoxemia in hypoxic-ischemic encephalopathy infants during whole-body hypothermia, while end-tidal Co 2 reliably correlates with temperaturecorrected Paco 2 . (Pediatr Crit Care Med 2018; 20:166-171) Key Words: acidosis; blood gas analysis; capnography; hypoxia; oxygen dissociation curve; pulmonary hypertension; pulse oximetry M oderate therapeutic hypothermia (33.5°C) is neuroprotective in infants who suffer from perinatal hypoxic-ischemic encephalopathy (HIE). The American Academy of Pediatrics (1) and Neonatal Resuscitation Program (2) support whole-body or selective head cooling for neonates with moderate to severe HIE. Neonates with HIE are at risk for neurodevelopmental impairment (NDI) and persistent pulmonary hypertension of the newborn (PPHN) (3) .
M oderate therapeutic hypothermia (33.5°C) is neuroprotective in infants who suffer from perinatal hypoxic-ischemic encephalopathy (HIE). The American Academy of Pediatrics (1) and Neonatal Resuscitation Program (2) support whole-body or selective head cooling for neonates with moderate to severe HIE. Neonates with HIE are at risk for neurodevelopmental impairment (NDI) and persistent pulmonary hypertension of the newborn (PPHN) (3) .
A meta-analysis of four major cooling trials involving 614 infants demonstrated the incidence of PPHN and inhaled nitric oxide (iNO) although higher in infants with HIE, does not significantly increase with therapeutic hypothermia (4, 5) . In a recent trial of optimizing cooling strategies, whole-body hypothermia to 32°C increased need for iNO therapy (34% vs 24%) and extracorporeal membrane oxygenation (ECMO) (9% vs 4%) compared with 33.5°C. Clinical data on the incidence of PPHN during therapeutic hypothermia are conflicting but optimizing cooling trial and animal studies suggest that pulmonary vascular resistance (PVR) may increase during hypothermia by an unknown mechanism (7, 8) .
It is a common practice to monitor ventilated patients with respiratory monitors with capnography (end-tidal Co 2 [etco 2 ]) and pulse oximetry (Spo 2 ). Continuous monitoring with noninvasive variables such as etco 2 and Spo 2 are periodically trended with Paco 2 and Pao 2 measured with arterial blood gases (ABGs). The optimal ranges for Paco 2 and Pao 2 during whole-body hypothermia for HIE (with or without correction for body temperature) that minimizes the risk of NDI and PPHN are not known. Hypocapnia (9) and hyperoxia (10) are associated with an increased incidence of NDI in patients with HIE.
We studied the effect of whole-body hypothermia (33.5°C) on Pao 2 , Paco 2 , Spo 2 , and etco 2 from data in our unit. We hypothesized that the relationship between noninvasive measures of gas exchange (etco 2 and Spo 2 ) and Paco 2 and Pao 2 is altered during whole-body hypothermia.
METHODS
This study was approved by the Children and Youth Institutional Review Board of the University at Buffalo and waived need for individual consents. Philips patient monitoring system (Phillips IntelliVue MX800, N.V.; Philips, Andover, MA) was used for Spo 2 monitoring, Maquet Servo I ventilators (Maquet, Rastatt, Germany) (pressure mode of ventilation) for neonates was used for ventilation. For etco 2 monitoring we used Philips NM3 monitor (Respironics, Andover, MA), which measures Co 2 in exhaled air/ gas via infrared sensor, and Abbott i-STAT point of care (Abbott, Princeton, NJ) was used for blood gas analysis.
Data on Gas Exchange
For the retrospective chart review at the regional perinatal center, 74 neonates on whole-body hypothermia (33.5°C) for 72 hours for moderate to severe HIE between July 2009 and March 2016 were evaluated. Fifty-eight neonates who were intubated and had an indwelling arterial catheter (umbilical or peripheral) for blood draws were included in this study. The temperature for ventilator humidifier was set at 37°C throughout the study period. The data points were divided into two groups: normothermia and hypothermia (target~33.5°C) based on infant's esophageal temperature at the time of ABG collection. The following variables: Spo 2 , etco 2 were collected at the same time as blood draw. Data from 1,240 ABGs (383 during normothermia and 857 during hypothermia) with simultaneous Spo 2 measurements was extracted. Sixty-six ABG samples were drawn prior to initiation of hypothermia (during 1-6 hr after birth), 857 were drawn during hypothermia and the remaining 317 after rewarming (after day 3 but prior to removal of the indwelling arterial catheter). Temperature-corrected Pao 2 was plotted against Spo 2 and Paco 2 against etco 2 .
Statistical Analysis
Oxygen-hemoglobin dissociation curves were created for hypothermia and normothermia using corresponding Spo 2 and Pao 2 values. To account for the varying number of repeated measurements by infant, methods for clustered data were used. For within-measurement comparisons of temperature-corrected and uncorrected values, we compared mean differences scores using a clustered sample paired t test, using PROC SURVEYMEANS in SAS (SAS Institute, Cary, NC). For comparing normothermic to hypothermic measurements, we fit clustered data regression models using PROC GLIMMIX (SAS Institute, Cary, NC) in SAS with robust ses. For comparing clinical variables, regression models were specified with fixed effects for infant and hypothermia status, to estimate adjusted mean within-infant differences, analogously to a paired t test but accounting for the unbalanced number of hypothermic and normothermic measurements. For fitting dissociation curves, we specified random intercepts for infants. We modeled log-transformed Pao 2 (dependent variable) as a function of logit-transformed Spo 2 and hypothermia status, and we used untransformed values to model Paco 2 (dependent variable) as a function of etco 2 and hypothermia status. Spo 2 values of 100% were logit-transformed to log (99.75%/0.25%). Models were fit with and without interactions of hypothermia status and the covariate, to assess whether hypothermia modified the fitted slope, using the traditional significance threshold (p < 0.05) for the interaction term to select the better fitting model. The regression coefficient for hypothermia status predicting log-transformed Paco 2 was back-transformed (via the inverse natural logarithm, aka "exponentiation") to the original scale for Paco 2 , and thus represents an adjusted geometric mean ratio, expressing the relative effects of hypothermia on typical predicted values.
RESULTS
During the study period, 34 males and 24 female infants underwent moderate whole-body hypothermia protocol and had an indwelling arterial catheter. None of the infants were passively cooled prior to admission and had an esophageal temperature of greater than or equal to 36.5°C prior to onset of therapeutic hypothermia. Median Apgar scores were 2 (interquartile range [IQR], 1-3), 5 (4-6), and 5 (4-6) at 1, 5 and 10 minutes respectively. Cord pH was 6.9 ± 0.19. Twelve infants had severe and 46 infants had moderate HIE by modified Sarnat staging (11) . Eleven infants (19.6%) had echocardiographic findings of PPHN, seven infants (12.5%) required iNO, and none were placed on ECMO. Six infants (10.7%) died prior to discharge. The cause of death was withdrawal of support due to severe HIE in five infants. One infant had hypoxemia due to PPHN and severe HIE and was not placed on ECMO following a discussion with parents. Fig. 1A ) (12) . Interestingly, there were 440 ABGs corresponding to Spo 2 of 100% with Fio 2 ranging from 0.21 to 1.0 and Pao 2 ranging from 30 to 425 mm Hg (4.00-56.66 kPa) (Fig. 1A) . Maintaining Spo 2 between 95 and 99% during hypothermia corresponded to Pao 2 values were between 60 and 90 mm Hg (Fig. 2) .
Oxygen Monitoring

Co 2 Monitoring
Correction of blood gases to patient's temperature during wholebody hypothermia (33.5°C) significantly reduced median (IQR) Paco 2 values from 49 mm Hg (43-56 mm Hg) to 42 mm Hg (37-48 mm Hg) (6.5 kPa [5.7-7.5 kPa] to 5.6 kPa [4.93-6.40] kPa) (p < 0.001) ( Table 1) . etco 2 was marginally lower than Paco 2 (corrected for body temperature) during hypothermia and normothermia (Fig. 1B) and the gradient between arterial and end-tidal Paco 2 was low during both normothermia (median, 1 torr [0.13 kPa]; IQR, -2 to 4) and hypothermia (median, 3 mm Hg; IQR, 0-7). Although Paco 2 uncorrected for body temperature was significantly higher, capnography accurately estimated Paco 2 levels (corrected for temperature) during hypothermia (Fig. 1B) . In mixed-effects modeling, the adjusted hypothermia versus normothermia mean difference in Paco 2 levels was not significant (-0.10 [95% CI, -4.47 to 4.27]; p = 0.96).
Oxygen-Hemoglobin Dissociation
The best fitting model included fixed effects for logittransformed Spo 2 and hypothermia status. Hypothermia significantly shifted the fitted dissociation curve to the left, corresponding to a relative underestimation of geometric mean Pao 2 by 23% (adjusted hypothermia vs normothermia geometric mean ratio Pao 2 = 0.77 [95% CI, 0.73-0.81]).
DISCUSSION
The benefits of hypothermia in reducing mortality and NDI are well established in infants with HIE. Optimizing cerebral a p for hypothermia vs normothermia adjusted mean difference, estimated using a clustered data regression model with fixed-effects for ID (58 infants) and hypothermia, a method that generalizes the paired t test to account for the varying and unbalanced numbers of normothermic and hypothermic repeated measures by infant. Robust ses were used to protect against departures from modeling assumptions. b Significantly different from corresponding measurement at 37°C, by one-sample t test for mean difference score, adjusted for clustering by ID, a method that generalizes the paired t test to account for clustering by ID (these tests were conducted separately in normothermic and in hypothermic measurements).
and pulmonary hemodynamics during hypothermia may be important to optimize outcomes in HIE. Two acid-base management approaches during hypothermia are described in the literature in reference to pediatric cardiac anesthesia management and profound hypothermia (usually 18-20°C) (7, 13). However, there are no studies evaluating the optimal approach to acid-base management during mild hypothermia (33-34°C) for HIE. Management by the "α-stat technique" focuses on maintaining a normal pH and Paco 2 at 37°C and not at the current body temperature (7).
In the "pH-stat technique," Paco 2 in the blood gas drawn from a hypothermic patient is measured after warming the blood to 37°C but is mathematically corrected to the patient's temperature (7) . Ventilation is then adjusted to achieve a normal pH and Paco 2 at patient's temperature. This results in higher Co 2 (as compared with the α-stat method), and leads to concurrent cerebral vasodilation and pulmonary vasoconstriction, resulting in higher cerebral blood flow and more effective and homogenous brain cooling. In addition, animal studies demonstrate better suppression of cerebral metabolic rate with pH-stat method (7). Thus, based on literature review almost all studies evaluating whole-body hypothermia for HIE have adapted pH-stat method for acid-base management (6, 11, 14, 15) . Data on neurodevelopmental outcome and incidence of PPHN from these trials are based on blood gases corrected for body temperature. However, our survey conducted among Neonatology Division chiefs from U.S. institutions suggests that, only 64% of academic divisions exclusively report corrected blood gases during hypothermia ( Table 1) . As expected, we found that that correction for actual body temperature during hypothermia decreased Pao 2 and the Paco 2 (Table 1) . According to Henry's law, the solubility of gas within liquid increases with a decrease in temperature of the liquid. This means that as it cools, plasma can have more dissolved gases but at a lower Paco 2 and Pao 2 (7) . Maintenance of the same Paco 2 or Pao 2 under hypothermic conditions will require greater Co 2 or oxygen content. No trial to date has prospectively examined the association between hypocarbia and hypercarbia with PPHN and neurodevelopmental outcome following therapeutic hypothermia for HIE. In a post hoc analysis of the Eunice Kennedy Shriver National Institute of Child Health and Human Development cooling trial, hypocarbia (Paco 2 < 35 mm Hg [4.67 kPa]) corrected for body temperature was associated with higher rates of death and poor neurodevelopmental outcome (9) . Similar results were reported from a retrospective analysis of CoolCap trial using corrected blood gases (16) . Fluctuations in Paco 2 levels during 72 hours of whole-body hypothermia is also associated with poor neurodevelopmental outcome (16 (12, 19) . Hyperoxemia during the initial NICU course increased the incidence of NDI but did not reduce PPHN among patients with HIE (10) . Hence, to maintain low PVR and avoid adverse neurodevelopmental outcome, from an arterial oxygenation standpoint it may be prudent to maintain Pao 2 (corrected for body temperature) between 60 and 80 mm Hg (18) .
Fetal hemoglobin is adapted to operate at a lower Pao 2 than adult hemoglobin, and its fetal oxyhemoglobin dissociation curve is shifted to the left. The further leftward shift in fetal oxyhemoglobin dissociation curve induced by hypothermia has a profound influence on Pao 2 levels at lower saturations, as shown in Figure 2 . For a given Spo 2 , Pao 2 was significantly decreased during hypothermia in our patients (Fig. 1A) . Thus, the use of uncorrected blood gases at 37°C and Spo 2 monitoring can underestimate hypoxemia during hypothermia.
What is the significance of these findings in clinical practice? Hypocapnia is common in HIE; 40% of moderate and 67% of severe HIE patients presented with Paco 2 less than 30 mm Hg (4 kPa) at randomization in the CoolCap trial (16) . Minimizing the severity and duration of hypocapnia and reducing fluctuations in Paco 2 is of paramount importance to improve outcomes in HIE. We recommend frequent blood gas monitoring and maintaining temperature-corrected Paco 2 between 40 and 50 mm Hg (5.3-6.67 kPa) during hypothermia (9, 10, 16) . We conducted a survey among chiefs of Neonatal Perinatal Medicine evaluating invasive and noninvasive assessment of gas exchange during hypothermia. Our survey suggests that this target range for Paco 2 is preferred by academic institutions in the United States (see supplement, Supplemental Digital Content 1, http:// links.lww.com/PCC/A797). etco 2 provides a reliable measure of temperature corrected Paco 2 and the recommended range based on our study is 41-45 mm Hg (5.47-6 kPa) (Fig. 1B) .
Hypoxemia and hyperoxemia are common in patients with HIE and are associated with an increased risk of PPHN (19) . Based on our findings, uncorrected Pao 2 and Spo 2 are unreliable during hypothermia (Figs. 1A and 2 ). We recommend close monitoring and maintaining temperature-corrected Pao 2 between 60 and 80 mm Hg (8) (9) (10) .66 kPa) during therapeutic hypothermia for HIE.
The limitations of our study include its retrospective nature and some of the arterial gases may have been post ductal. These differences may have influenced our results. Multiple samples were obtained from the same patient and to offset the difference we have used robust regression model. The number of blood gases before and after the onset of hypothermia are lower than that during hypothermia. We did not measure the percentage of fetal hemoglobin in these samples. Variations in the level of 2,3 diphosphoglycerate may have contributed to changes in oxygen-hemoglobin dissociation curve. As noted above, the ventilator humidifier was set at 37°C as a standard practice throughout the cooling and rewarming process, so the measured etco 2 may have been at a somewhat higher temperature than neonatal core temperature during hypothermia. Regardless, these findings have never been studied in neonates and is important in managing neonates with HIE undergoing whole-body hypothermia.
With the current evidence from translational and clinical studies, we conclude that correcting blood gases to patient's temperature may aid in unnecessary fluctuations in Paco 2 and Pao 2 which may influence cerebral blood flow and maintain oxygen delivery to the brain. We recommend frequent blood gas monitoring with less reliance on Spo 2 during whole-body hypothermia, especially in patients at risk for PPHN. Further prospective studies evaluating the optimal approach to acidbase management and target Spo 2 and etco 2 during hypothermia for HIE are warranted.
